EXMceuticals Inc. Announces Loan Settlement and Share Issuance

July 28, 2020

VANCOUVER, BRITISH COLUMBIA, July 28, 2020 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the “Company” or “EXM”) is pleased to announce that further to its news release dated July 22, 2020, pursuant to certain loan agreements previously entered into between ...

EXMceuticals Inc. Announces Closing of Oversubscribed Private Placement and Strategic Debt to Equity Conversion Strengthening the Corporation’s Balance Sheet

July 22, 2020

VANCOUVER, BRITISH COLUMBIA, July 22nd, 2020 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM") is pleased to announce that it has completed the sale of 5,180,000 units on a private placement basis at a price of $0.20 ...

EXMceuticals Inc. Strengthens Positioning as a Gateway to the European Market through Supply Agreement for THC Distillate

June 10, 2020

VANCOUVER, BRITISH COLUMBIA, June 11, 2020 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM"), is pleased to announce that it has entered into a letter of intent ("LOI") with Econnabis SAS, an operating subsidiary of Plena Global ...

EXMceuticals Inc. Secures Supply & Offtake Agreements-In-Principle for Proposed Portugal Refinery

May 07, 2020

VANCOUVER, BRITISH COLUMBIA, May 7th, 2020 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM"), an emerging producer of refined cannabis ingredients serving the pharmaceutical, medical, nutraceutical, and cosmetic industries, has secured supply agreements-in-principle of pharmaceutical/medical grade cannabis ...

EXMceuticals Inc. provides an update on operations and announces first closing of loan agreement

March 25, 2020

VANCOUVER, BRITISH COLUMBIA, March 25, 2020 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the "Company" or "EXM"), a producer of refined cannabis ingredients for the pharmaceutical, medical, nutraceutical, and cosmetic industries, provides an update on our operations, the first closing ...

EXMceuticals Inc. provides an update on activities and announces a new Board Member and Corporate Secretary

March 02, 2020

VANCOUVER, BRITISH COLUMBIA, March 03, 2020 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a producer of cannabis extractions and refined ingredients for the pharmaceutical, nutraceutical, therapeutical and cosmetic industries, is pleased to give a brief update ...

EXMceuticals Inc. appoints Michael Kinley as CFO

February 06, 2020

Vancouver, British Columbia, February 6, 2020 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a producer of high-grade cannabis extracted ingredients for the pharmaceutical, nutraceutical, therapeutical and cosmetic industries, is pleased to announce the appointment of Michael ...

EXMceuticals Inc. appoints Prf. Dr. Eurico Castro Alves as Board Advisor

February 03, 2020

Vancouver, British Columbia, February 3, 2020 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a producer of high-grade cannabis extracted ingredients for the pharmaceutical, nutraceutical, therapeutical and cosmetic industries, is pleased to announce it has appointed Prf. ...

EXMceuticals Inc. appoints Nick Davis as Board Advisor

January 20, 2020

EXMceuticals Inc. appoints Nick Davis as Board AdvisorVancouver, British Columbia, January 20th, 2020 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a producer of high-grade cannabis extracted ingredients for the pharmaceutical, nutraceutical, therapeutical and cosmetic industries, is ...

EXMceuticals Inc. names Paulo Martins as Chief Executive Officer for Portugal operations

January 14, 2020

EXMceuticals Inc. names Paulo Martins as Chief Executive Officer for Portugal operationsVANCOUVER, BRITISH COLUMBIA, January 14, 2020 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a producer of cannabis extractions and refined ingredients for the pharmaceutical, nutraceutical, ...